161 related articles for article (PubMed ID: 24099410)
1. The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
Ravassa S; Barba J; Coma-Canella I; Huerta A; López B; González A; Díez J
Cardiovasc Diabetol; 2013 Oct; 12():143. PubMed ID: 24099410
[TBL] [Abstract][Full Text] [Related]
2. The neurogenic response of cardiac resident nestin(+) cells was associated with GAP43 upregulation and abrogated in a setting of type I diabetes.
Chabot A; Meus MA; Hertig V; Duquette N; Calderone A
Cardiovasc Diabetol; 2013 Aug; 12():114. PubMed ID: 23938193
[TBL] [Abstract][Full Text] [Related]
3. Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction.
Li JW; Chen YD; Liu YQ; Wang JD; Chen WR; Zhang YQ; Ma Q
Sci Rep; 2017 Jul; 7(1):6097. PubMed ID: 28733630
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia-reperfusion injury in rats with diabetes mellitus type 2.
Bradic J; Milosavljevic I; Bolevich S; Litvitskiy PF; Jeremic N; Bolevich S; Zivkovic V; Srejovic I; Jeremic J; Jovicic N; Mitrovic S; Jakovljevic V
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):575-584. PubMed ID: 33352623
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
7. DPP4 Inhibition Ameliorates Cardiac Function by Blocking the Cleavage of HMGB1 in Diabetic Mice After Myocardial Infarction.
Sato A; Suzuki S; Watanabe S; Shimizu T; Nakamura Y; Misaka T; Yokokawa T; Shishido T; Saitoh SI; Ishida T; Kubota I; Takeishi Y
Int Heart J; 2017 Oct; 58(5):778-786. PubMed ID: 28966327
[TBL] [Abstract][Full Text] [Related]
8. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
[TBL] [Abstract][Full Text] [Related]
9. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls.
Ofstad AP; Urheim S; Dalen H; Orvik E; Birkeland KI; Gullestad L; W Fagerland M; Johansen OE; Aakhus S
J Diabetes; 2015 Nov; 7(6):779-90. PubMed ID: 25350248
[TBL] [Abstract][Full Text] [Related]
10. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
12. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions.
Shigeta T; Aoyama M; Bando YK; Monji A; Mitsui T; Takatsu M; Cheng XW; Okumura T; Hirashiki A; Nagata K; Murohara T
Circulation; 2012 Oct; 126(15):1838-51. PubMed ID: 23035207
[TBL] [Abstract][Full Text] [Related]
14. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
[TBL] [Abstract][Full Text] [Related]
16. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
Yamada H; Tanaka A; Kusunose K; Amano R; Matsuhisa M; Daida H; Ito M; Tsutsui H; Nanasato M; Kamiya H; Bando YK; Odawara M; Yoshida H; Murohara T; Sata M; Node K;
Cardiovasc Diabetol; 2017 May; 16(1):63. PubMed ID: 28490337
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
[TBL] [Abstract][Full Text] [Related]
18. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients.
Sarkar J; Nargis T; Tantia O; Ghosh S; Chakrabarti P
Front Endocrinol (Lausanne); 2019; 10():505. PubMed ID: 31402899
[No Abstract] [Full Text] [Related]
19. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
[TBL] [Abstract][Full Text] [Related]
20. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
Cioffi G; Giorda CB; Chinali M; Di Lenarda A; Faggiano P; Lucci D; Maggioni AP; Masson S; Mureddu GF; Tarantini L; Velussi M; Comaschi M;
Eur J Prev Cardiol; 2012 Oct; 19(5):935-43. PubMed ID: 21798988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
